Delivra Health Brands stock analysis
Want to see TSE:DHB full AI Analyst Report?
Delivra Health Brands (DHB) Stock Price & Analysis
DHB Stock Chart & Stats
- Day’s Range
- CAD 0.08 - CAD 0.09
- 52-Week Range
- CAD 0.07 - CAD 0.32
- Previous Close
- CAD 0.09
- Volume
- N/A
- Average Volume (3M)
- 8,948
- Market Cap
- CAD 2.66M
- Enterprise Value
- CAD 3.92M
- Total Cash (Recent Filing)
- CAD 2.85M
- Total Debt (Recent Filing)
- CAD 2.41M
- Price to Earnings (P/E)
- ―
- Beta
- 1.99
- Next Earnings
- Nov 30, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Portfolio And Channel Diversification
A portfolio-based model spanning pain management, personal care, retail, contract manufacturing, and distribution gives Delivra multiple routes to market. This breadth can support brand development and reduce reliance on one product line or customer channel over the coming quarters.
Losses Improved Versus Historical Extremes
Although the latest results remain unprofitable, losses are materially below the extreme levels recorded in 2021–2022. That improvement indicates some longer-term operational recovery has occurred, providing a more stable base if management can restore revenue and margins.
Cash Burn Has Narrowed
Free cash flow remains negative, but the loss narrowed from 2025 and is substantially better than the 2021–2022 period. Reduced cash burn can preserve financial runway and improve self-funding potential if the company continues moving toward positive operating cash flow.
Bears Say
Sharp Revenue Contraction
A sharp annual revenue decline reverses the company’s prior growth pattern and weakens the scale supporting its brand portfolio. Unless demand and distribution recover, lower sales can limit operating leverage, reduce reinvestment capacity, and prolong the path to sustainable profitability.
Margin Compression And Renewed Losses
The combination of materially lower gross margin and renewed net losses indicates that recent revenue is producing less economic value. Persistent margin pressure would constrain the company’s ability to cover fixed costs, fund product development, and achieve durable earnings improvement.
Rising Leverage And Negative Cash Flow
Higher debt relative to a shrinking equity base reduces financial flexibility while negative operating and free cash flow weaken internal funding. If profitability does not stabilize, Delivra may have less capacity to absorb setbacks, invest in growth, or manage ongoing financial obligations.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
What is Delivra Health Brands’s market cap?
When is Delivra Health Brands’s upcoming earnings report date?
How were Delivra Health Brands’s earnings last quarter?
Is Delivra Health Brands overvalued?
Does Delivra Health Brands pay dividends?
What is Delivra Health Brands’s EPS estimate?
How many shares outstanding does Delivra Health Brands have?
What happened to Delivra Health Brands’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Delivra Health Brands?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Delivra Health Brands
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Gord Davey
- Employees
- 22
- Website
- delivrahealthbrands.com
- Address
- 999 Canada Place, Vancouver, BC, V6C 3E2, CA
Delivra Health Brands (DHB) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 3 | 15 |
| Technical Analysis | 3 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |








